Background

The Drug Enforcement Administration has issued an order temporarily including the synthetic opioid N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryl fentanyl or acryloylfentanyl), as well as its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, into schedule I of the Controlled Substances Act. Available data and information indicate that this substance has a high potential for abuse, no currently accepted medical use in treatment in the U.S., and a lack of accepted safety for use under medical supervision.

This order imposes the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I substances under the CSA on the importation, exportation, manufacture, distribution, reverse distribution, possession, research and conduct of instructional activities, and chemical analysis of this substance. It is effective as of July 14 and will remain in effect until July 15, 2019, unless it is extended for an additional year or a permanent scheduling proceeding is completed.

Close

Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.